Caporali, R., R. Ravasio, P. Raimondo, and F. Salaffi. “Cost Per Responder for Upadacitinib Vs Abatacept in Patients With Moderate-to-Severe Rheumatoid Arthritis in Italy”. Global and Regional Health Technology Assessment, vol. 8, no. 1, July 2021, pp. 69-79, doi:10.33393/grhta.2021.2267.